Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Yangjin Jegal, Jong Sun Park, Song Yee Kim, Hongseok Yoo, Sung Hwan Jeong, Jin Woo Song, Jae Ha Lee, Hong Lyeol Lee, Sun Mi Choi, Young Whan Kim, Yong Hyun Kim, Hye Sook Choi, Jongmin Lee, Soo-Taek Uh, Tae-Hyung Kim, Sang-Heon Kim, Won-Yeon Lee, Yee Hyung Kim, Hyun-kyung Lee, Eun Joo Lee, Eun Young Heo, Sei Hoon Yang, Hyung Koo Kang, Man Pyo Chung,
Tuberc Respir Dis. 2022;85(2):185-194.   Published online 2021 Dec 13     DOI: https://doi.org/10.4046/trd.2021.0123
Citations to this article as recorded by Crossref logo
Rethinking treatment strategies for idiopathic pulmonary fibrosis: Reevaluation of anti-inflammatory and immunosuppressive therapies
Masashi Bando
Respiratory Investigation.2023; 61(1): 58.     CrossRef
Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
Samy Suissa, Karine Suissa
American Journal of Respiratory and Critical Care Medicine.2023; 207(1): 105.     CrossRef
Outcomes of Patients on the Lung Transplantation Waitlist in Korea: A Korean Network for Organ Sharing Data Analysis
Hye Ju Yeo, Dong Kyu Oh, Woo Sik Yu, Sun Mi Choi, Kyeongman Jeon, Mihyang Ha, Jin Gu Lee, Woo Hyun Cho, Young Tae Kim
Journal of Korean Medical Science.2022;[Epub]     CrossRef